You are here: Fairness.com > Resources > Schools' Backing of Behavior Drugs ...

Schools' Backing of Behavior Drugs Comes Under Fire

Date: August 19, 2001

Author: Kate Zernike

QUOTE: Children return to classrooms this fall amid an increasingly pitched battle over Ritalin and other drugs used to treat millions with behavioral and emotional problems...

ABSTRACT: Amid growing concerns about over-prescription and abuse of behavioral/emotional managament medications amongst school age children, many states are considering legislation that forbids educational institutions and personnel from becoming involved in any way in any recommendations for children to be so treated, and many pharmaceutical companies are turning to direct-to-parent advertising for newer behavioural management pharmaceuticals now appearing on the market...

• Read it: New York Times
• Tell a friend
• Add a Comment*

Article MetaInformation:

Key People:

• Prof. Howard Abikoff M.D.

Key Organizations:

• Celltech Pharmaceuticals
• Drug Enforcement Administration (DEA)
• New York Times Company
• Novartis AG
• Ortho-McNeil Pharmaceutical
• Shire Pharmaceuticals Group

Subject & Geographic Categories:

• Businesses & Organizations
  • Sales & Marketing
    • Sales/Selling
      • Producer-Customer Relations (B-to-B)

• Education
  • Student Behavior

• Health & Medicine
  • Drugs: Prescription/Non-Prescription
  • Health Care Business
    • Pharmaceutical / Drug / Biotech

• Media & Journalism
  • Advertising: General
    • Advertising: Intrusiveness/Taste

• North America
  • United States of America/USA

Comments:

none

• Add a Comment*

*User comments are posted without Fairness.com LLC's prior review or approval, and Fairness.com LLC takes no responsibility for them; please see our Conditions of Service Agreement.

Please send your comments and suggestions to the Webmaster. © copyright 1999-2009, Fairness.com LLC.
"Fairness.com" and "Life isn't fair... but we're working on it" are service marks of Fairness.com LLC. All rights reserved.